Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer
NCT03871205
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Carcinoma, Non-Small Cell Lung
Carcinoma, Small Cell Lung
Interventions
BIOLOGICAL:
Neoantigen loaded DC vaccine
Sponsor
Shenzhen People's Hospital